Ryvu Therapeutics SA's total assets for Q1 2025 were zł318.50M, a decrease of -15.91% from the previous quarter. DE:9Y4 total liabilities were zł198.90M for the fiscal quarter, a -15.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.